ADBIOTECH Calls Extraordinary General Meeting to Approve Business Expansion and Director Elections

ADBIOTECH will hold an extraordinary general meeting on June 19, 2026 to amend its articles of incorporation, adding over 20 new business purposes including pet funeral services, clinical pathology, and medical device manufacturing, diversifying its operations.
The agenda also includes the election of three inside directors and two outside directors. Outside director candidates Professor Noh Yun-seok of Chungbuk National University and Professor Kang Jun-gu of Jeonbuk National University are expected to enhance board transparency with their veterinary and medical expertise.
This disclosure involves no capital changes or financial impact; it is a governance improvement and business expansion proposal that does not immediately dilute or harm existing shareholder value.
[AI Summary]ADBIOTECH's extraordinary general meeting focuses on expanding business scope and restructuring the board without additional capital raising, resulting in limited short-term shareholder value impact. Considering potential synergies with its core veterinary medicine business, this move is positive for securing mid-to-long-term growth drivers.